Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AB5152-200UL Anti-Calcium Channel Antibody, Voltage Gated α 1A

AB5152-200UL
200 µL  
Purchase on Sigma-Aldrich

特卖

概述

Replacement Information

重要规格表

Species ReactivityKey ApplicationsHostFormatAntibody Type
M, RICC, IP, WBRbAffinity PurifiedPolyclonal Antibody
Description
Catalogue NumberAB5152-200UL
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Calcium Channel Antibody, Voltage Gated α 1A
Alternate Names
  • P/Q-type
References
Product Information
FormatAffinity Purified
Control
  • CONTROL ANTIGEN: Included free of charge with the antibody is 20 μg of control antigen (lyophilized powder). The stock solution of the antigen can be made up using 100 μL of sterile deionized water. For negative control, preincubate 1 μg of peptide with 10 μg of antibody for one hour at room temperature. Optimal concentrations must be determined by the end user.
PresentationAffinity purified immunoglobulin. Lyophilized from phosphate buffered saline, pH 7.4, containing 1% BSA and 0.05% sodium azide as a preservative. Reconstitute with 200 μL of sterile deionized water.

Centrifuge antibody preparation

before use (10,000 x g for 5 min).
Quality SegmentMQ100
Applications
ApplicationThis Anti-Calcium Channel Antibody, Voltage Gated α 1A is validated for use in IC, IP, WB for the detection of Calcium Channel.
Key Applications
  • Immunocytochemistry
  • Immunoprecipitation
  • Western Blotting
Application Notes

All procedures that are going to receive a full-length protein should be performed at 4 °C, and the following protease inhibitor mixture should be used: pepstatin A (1 mg/mL), leupeptin (1 mg/mL), aprotinin (1 mg/mL), Pefabloc SC (0.2 mM), benzamidine (0.1 mg/mL), and calpain inhibitors I and II (8 mg/mL each).

Western blot: 1:200 using ECL on rat brain membranes.

Immunohistochemistry on rat brain sections.Dilutions should be made using a carrier protein such as BSA (1-3%)

Optimal working dilutions must be determined by the end user.

Immunocytochemistry: 5 μg/mL (1:60).

Recommend subsequent staining with a labeled second antibody.

Western blot: 1.5 μg/mL (1:200) using ECL

Dilutions should be made using a carrier protein such as BSA (1-3%)

Optimal working dilutions must be determined by the end user.
Biological Information
ImmunogenPurified peptide CNA1 from 865-881 of alpha 1A subunit of rat brain voltage-gated calcium channel (Starr,

1991) (Accession

P54282) containing N-terminal lysine and

tyrosine, conjugated to KLH with

gluteraldehyde

(Westenbroek et al. 1995).
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostRabbit
SpecificityRecognizes Cav2.1 (alpha 1A subunit, P/Q-type of voltage-gated calcium channel, Cacna1a). Does not cross react with any other calcium channel proteins tested so far.
Species Reactivity
  • Mouse
  • Rat
Antibody TypePolyclonal Antibody
Entrez Gene Number
Entrez Gene SummaryVoltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants have been described, however, the full-length nature of not all is known. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-16 to 21-28 in the coding region is associated with spinocerebellar ataxia 6.
Gene Symbol
  • CACNA1A
  • FHM
  • CAV2.1
  • CACNL1A4
  • SCA6
  • BI
  • HPCA
  • CACN3
  • MHP1
  • Cav2.1
  • CACH4
  • APCA
  • MHP
  • EA2
UniProt Number
UniProt SummaryFUNCTION: SwissProt: O00555 # Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1A gives rise to P and/or Q-type calcium currents. P/Q-type calcium channels belong to the high-voltage activated (HVA) group and are blocked by the funnel toxin (Ftx) and by the omega-agatoxin- IVA (omega-Aga-IVA). They are however insensitive to dihydropyridines (DHP), and omega-conotoxin-GVIA (omega-CTx-GVIA).
SIZE: 2505 amino acids; 282365 Da
SUBUNIT: Voltage-dependent calcium channels are multisubunit complexes, consisting of alpha-1, alpha-2, beta and delta subunits in a 1:1:1:1 ratio. The channel activity is directed by the pore- forming and voltage-sensitive alpha-1 subunit. In many cases, this subunit is sufficient to generate voltage-sensitive calcium channel activity. The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity.
SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
TISSUE SPECIFICITY: Brain specific; mainly found in cerebellum, cerebral cortex, thalamus and hypothalamus. No expression in heart, kidney, liver or muscle. Purkinje cells contain predominantly P-type VSCC, the Q-type being a prominent calcium current in cerebellar granule cells.
DOMAIN: SwissProt: O00555 Each of the four internal repeats contains five hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one positively charged transmembrane segment (S4). S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position.
DISEASE: SwissProt: O00555 # Defects in CACNA1A are the cause of spinocerebellar ataxia 6 (SCA6) [MIM:183086]. Spinocerebellar ataxia is a clinically and genetically heterogeneous group of autosomal dominant cerebellar ataxias (ADCA). Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements. Spinocerebellar ataxia is caused by degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA6 is caused by expansion of a CAG repeat in the coding region of CACNA1A. There seems to be a correlation between the repeat number and earlier onset of the disorder. & Defects in CACNA1A are the cause of familial hemiplegic migraine (FHM) [MIM:141500]; also known as migraine familial hemiplegic 1 (MHP1). FHM, a rare autosomal dominant subtype of migraine with aura, is associated with ictal hemiparesis and, in some families, progressive cerebellar atrophy. & Defects in CACNA1A are the cause of episodic ataxia type 2 (EA-2) [MIM:108500]; also known as acetazolamide-responsive hereditary paroxysmal cerebellar ataxia (APCA). This autosomal dominant disorder is characterized by acetozolamide-responsive attacks of cerebellar ataxia and migraine-like symptoms, interictal nystagmus, and cerebellar atrophy.
SIMILARITY: Belongs to the calcium channel alpha-1 subunit family.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain lyophilized material at -20°C for up to 12 months after date of receipt. After reconstitution add glycerol (ASC gade or better at a ratio of 1:1 and maintain at -20°C for up to 6 months. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size200 µL
Transport Information
Supplemental Information
Specifications
Global Trade ITEM Number
产品目录编号 GTIN
AB5152-200UL 04053252677281

Documentation

Anti-Calcium Channel Antibody, Voltage Gated α 1A MSDS

职位

物料安全数据表 (MSDS) 

Anti-Calcium Channel Antibody, Voltage Gated α 1A 分析证书

标题批号
ANTI-CALCIUM CHANNEL, VOLTAGE GATED 1A AFFINITY PURIFIED POLYCLONAL ANTIBODY - 2019765 2019765
ANTI-CALCIUM CHANNEL, VOLTAGE GATED 1A AFFINITY PURIFIED POLYCLONAL ANTIBODY - 2172677 2172677
ANTI-CALCIUM CHANNEL, VOLTAGE GATED 1A AFFINITY PURIFIED POLYCLONAL ANTIBODY - 2207152 2207152
ANTI-CALCIUM CHANNEL, VOLTAGE GATED 1A AFFINITY PURIFIED POLYCLONAL ANTIBODY - 2361785 2361785
ANTI-CALCIUM CHANNEL, VOLTAGE GATED #945; 1A AFFINITY PURIFIED POLYCLONAL ANTIBODY - 2115876 2115876
ANTI-CALCIUM CHANNEL, VOLTAGE GATED α 1A - 3487093 3487093
ANTI-CALCIUM CHANNEL, VOLTAGE GATED α 1A -2529861 2529861
ANTI-CALCIUM CHANNEL, VOLTAGE GATED α 1A -2636725 2636725
ANTI-CALCIUM CHANNEL, VOLTAGE GATED α 1A AFFINITY PURIFIED POLYCLONAL ANTIBODY 2483174

参考

参考概述公共医疗ID
Assembly of presynaptic active zones from cytoplasmic transport packets.
Ahmari, S E, et al.
Nat. Neurosci., 3: 445-51 (2000)  2000

显示摘要
10769383 10769383
Voltage-dependent Ca(2+) channel subunit expression and immunolocalization in mouse spermatogenic cells and sperm.
Serrano, C J, et al.
FEBS Lett., 462: 171-6 (1999)  1999

显示摘要
10580114 10580114

数据表

标题
ANTI-CALCIUM CHANNEL, VOLTAGE GATED α 1A AFFINITY PURIFIED POLYCLONAL ANTIBODY